Company intelligence / Profile preview

YPB Group

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

YPB has deployed its authentication and consumer engagement solutions across over a billion product units worldwide[1]. The company has secured major pharmaceutical contracts, including a three-year contract expected to generate approximately $1 million in revenue[6]. Recent expansions include entry into the Chinese pharmaceutical market through partnerships with packaging suppliers[2].

Industry: Chemicals & Materials

Partnerships

Suzhou-Haishun Packaging Material Co. Ltd (pharmaceutical packaging)Beijing Haihui Printing Co. Ltd (anti-counterfeiting label printing)Combiphar (pharmaceutical)

Beyond the preview

Go deeper on YPB Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YPB Group.

Explore the full profile